FDA warns companies of using claims to treat cardiovascular disease
USA
Nov 17, 2022
The U.S. Food and Drug Administration issued warning letters to seven companies for illegally selling dietary supplements that claim to cure, treat, mitigate or prevent cardiovascular disease or related conditions, such as atherosclerosis, stroke or heart failure, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FDA is urging consumers not to use these or similar products because they have not been evaluated by the FDA to be safe or effective for their intended use and may be harmful.
For further information (in English), click on the Link
USA - A new era for food in health? The FDA announces a qualified health claim for yogurt intake and type II diabetes mellitus risk reduction
USA
Apr 16, 2024
BFSA publishes draft regulation on food advertising and claims
Bangladesh
Mar 18, 2024
FDA endorses Qualified Health Claim for Yogurt and Reduced Risk of Type 2 Diabetes Mellitus
USA
Mar 07, 2024
USA - Food-Derived Bioactive Components and Health ClaimsThe Role of Regulatory Agencies
USA
Mar 04, 2024
New enforcement measure for health and nutrition claims regulation
UK
Mar 01, 2024
FDA denies petition for qualified health claim for D-tagatose and reduced risk of type II diabetes
USA
Feb 27, 2024
UK - The Prevalence and Compliance of Health Claims Used in the Labelling and Information for Prepacked Foods within Great Britain
UK
Feb 07, 2024
FDA amends health claims regulation
Thailand
Jan 24, 2024
Parliament Implementation report on Regulation (EC) No 1924/2006 (nutrition and health claims)
European Union
Jan 22, 2024
ASA issues supplementary advice on health claims in dietary supplement ads
UK
Jan 17, 2024
Californian Court rules on misleading nutritional claim on dietary supplement
USA
Jan 11, 2024
New ingredients included in the Catalogue of Raw Materials for Health Food
China
Jan 09, 2024
China - The Suggestions for Improving the Management of Food Claims in China Based on International Experience
China
Dec 28, 2023
Anvisa publishes new Regulatory Agenda for 2024-2025
Brazil
Dec 20, 2023
ASA rules on unauthorized health claims
UK
Dec 06, 2023
